Douglas Arends
Psychiatry · Sterling Heights, MINPI 1780710475
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,257 and has fallen 77.5% since, to $508 in 2024. Among psychiatry clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $31.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$828
- Teva Pharmaceuticals USA, Inc.$724
- Neurocrine Biosciences, Inc.$586
- AbbVie$483
- Indivior Inc.$405
- Johnson & Johnson$391
- plus $1K from 12 others
What the payments were for
- Food & beverage$4,857100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 24 | $828 |
| Teva Pharmaceuticals USA, Inc. | 17 | $724 |
| Neurocrine Biosciences, Inc. | 20 | $586 |
| AbbVie | 19 | $483 |
| Indivior Inc. | 18 | $405 |
| Johnson & Johnson | 11 | $391 |
| Alkermes, Inc. | 7 | $258 |
| Acadia Pharmaceuticals Inc | 9 | $229 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $220 |
| Validus Pharmaceuticals LLC | 4 | $166 |
| Corium, LLC | 2 | $134 |
| Supernus Pharmaceuticals, Inc. | 1 | $120 |
| Lundbeck LLC | 5 | $115 |
| Avanir Pharmaceuticals, Inc. | 4 | $81 |
| Sun Pharmaceutical Industries Inc. | 4 | $75 |
| Neos Therapeutics, LP | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,857 in reported general payments places this provider in the 90th percentile of 1,166 psychiatry providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Topiramate | 45 | $554 |
| Quetiapine Fumarate | 11 | $406 |
| Doxepin Hcl | 11 | $371 |
| Duloxetine Hcl | 12 | $348 |
| Escitalopram Oxalate | 17 | $270 |
| Olanzapine | 11 | $219 |
| Bupropion XlBupropion Hcl | 11 | $164 |
| Aripiprazole | 11 | $162 |
| Sertraline Hcl | 11 | $102 |
| Clonazepam | 13 | $51 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Sterling Heights
- Robert BurnsteinSterling Heights$18K
- Edgard PedrazaSterling Heights$16K
- Robert PiccininiSterling Heights$12K
- Nina AndersonSterling Heights$12K
- Andreas SidiropoulasDetroit$2.8M
- Welton WashingtonYpsilanti$1.4M
- Joel YoungRochester Hills$1.1M
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Robert LagrouClarkston$267K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.